{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:25:31Z","timestamp":1790270731470,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902966"],"award-info":[{"award-number":["81902966"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102357","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:29:25Z","timestamp":1758788965000},"page":"102357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Lipid nanoparticle-mediated mRNA\/siRNA dual-bioengineered dendritic cell vaccines combined of PD-1\/PD-L1 blockade for boosting tumor immunotherapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Dong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4848-0640","authenticated-orcid":false,"given":"Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41565-020-00822-y","article-title":"Nanomaterials for T-cell cancer immunotherapy","volume":"16","author":"Gong","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41571-021-00552-7","article-title":"Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways","volume":"19","author":"Kraehenbuehl","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102357_bib3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3390\/cancers13102495","article-title":"Recent progress in dendritic cell-based cancer immunotherapy","volume":"13","author":"Matsuo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.mtbio.2025.102357_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114954","article-title":"Advances in dendritic cell vaccination therapy of cancer","volume":"164","author":"Najafi","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102357_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/cancers16050981","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"16","author":"Hato","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2096363","article-title":"Trial watch: dendritic cell (DC)-based immunotherapy for cancer","volume":"11","author":"Laureano","year":"2022","journal-title":"OncoImmunology"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102357_bib8","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-10-3126","article-title":"PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine","volume":"17","author":"Cheever","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102357_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41573-020-0074-8","article-title":"Antitumour dendritic cell vaccination in a priming and boosting approach","volume":"19","author":"Harari","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202400633","article-title":"Lipid Nanoparticle-mRNA engineered dendritic cell based adoptive cell therapy enhances cancer immune response","volume":"9","author":"Das","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.mtbio.2025.102357_bib11","article-title":"Dendritic cell subsets and implications for cancer immunotherapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.mtbio.2025.102357_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202318515","article-title":"Development of mannosylated lipid nanoparticles for mRNA cancer vaccine with high antigen presentation efficiency and immunomodulatory capability","volume":"63","author":"Lei","year":"2024","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102357_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41551-021-00795-w","article-title":"Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns","volume":"6","author":"Guo","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2025.102357_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2024.07.079","article-title":"Small extracellular vesicles carrying reovirus, tumor antigens, interferon-beta, and damage-associated molecular patterns for efficient tumor treatment","volume":"374","author":"Shuwari","year":"2024","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/acsnano.2c10797","article-title":"Blood clot scaffold loaded with liposome vaccine and siRNAs targeting PD-L1 and TIM-3 for effective DC activation and cancer immunotherapy","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.mtbio.2025.102357_bib17","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41551-021-00800-2","article-title":"Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells","volume":"5","author":"Liu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.mtbio.2025.102357_bib18","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mtbio.2025.102357_bib19","article-title":"PD-L1 siRNA incorporation into a cationic liposomal tumor mRNA vaccine enhances cytotoxic T cell activation and prevents immune evasion","volume":"31","author":"Zhou","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2025.102357_bib20","article-title":"PD-1\/PD-L1 checkpoint inhibitors in tumor immunotherapy","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mtbio.2025.102357_bib21","first-page":"211","article-title":"CD47KO\/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy","volume":"22","author":"Liu","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.102357_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101579","article-title":"Anion receptor-mediated multicomponent synergistic self-assembly of porphyrin for efficient phototherapy to elicit tumor immunotherapy","volume":"46","author":"Wang","year":"2022","journal-title":"Nano Today"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102357_bib23","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1021\/acsnano.3c10623","article-title":"A Versatile nanovaccine enhancement strategy based on suction-inspired physical therapy","volume":"18","author":"Wu","year":"2024","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102357_bib24","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.7150\/jca.57334","article-title":"A snapshot of the PD-1\/PD-L1 pathway","volume":"12","author":"Ghosh","year":"2021","journal-title":"J. Cancer"},{"issue":"27","key":"10.1016\/j.mtbio.2025.102357_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202314309","article-title":"A comprehensive strategy based on high clinical translational nanosystem for programmable immunotherapy of triple negative breast cancer","volume":"36","author":"Meng","year":"2024","journal-title":"Adv Mater"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2025.102357_bib27","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.102357_bib28","first-page":"273","article-title":"beta-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model","volume":"39","author":"Nelson","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.mtbio.2025.102357_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jconrel.2024.07.052","article-title":"Physicochemical and structural insights into lyophilized mRNA-LNP from lyoprotectant and buffer screenings","volume":"373","author":"Fan","year":"2024","journal-title":"J. Contr. Release"},{"issue":"17","key":"10.1016\/j.mtbio.2025.102357_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202410998","article-title":"A polymeric mRNA vaccine featuring enhanced site-specific mRNA delivery and inherent STING-stimulating performance for tumor immunotherapy","volume":"37","author":"Guo","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2025.102357_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijbiomac.2012.12.005","article-title":"Rehmannia glutinosa polysaccharide induces maturation of murine bone marrow derived dendritic cells (BMDCs)","volume":"54","author":"Zhang","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2025.102357_bib32","first-page":"167","article-title":"Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy","volume":"7","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102357_bib33","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7150\/thno.104698","article-title":"Optimized circular RNA vaccines for superior cancer immunotherapy","volume":"15","author":"Yu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2025.102357_bib34","article-title":"Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1\/PD-L1 blockade","volume":"27","author":"Jin","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.mtbio.2025.102357_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.actbio.2023.08.010","article-title":"A single-shot prophylactic tumor vaccine enabled by an injectable biomembrane hydrogel","volume":"169","author":"Nie","year":"2023","journal-title":"Acta Biomater."},{"issue":"42","key":"10.1016\/j.mtbio.2025.102357_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado6342","article-title":"Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance","volume":"10","author":"Pundavela","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2025.102357_bib37","article-title":"Prognostic role of serum cytokines level in non-small cell lung cancer patients with anti-PD-1 and chemotherapy combined treatment","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102357_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10457","article-title":"Co-delivery of dendritic cell vaccine and anti-PD-1 antibody with cryomicroneedles for combinational immunotherapy","volume":"8","author":"Chang","year":"2023","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-022-00257-2","article-title":"Research progress on dendritic cell vaccines in cancer immunotherapy","volume":"11","author":"Yu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2025.102357_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.730824","article-title":"Recent advances in experimental dendritic cell vaccines for cancer","volume":"11","author":"Filin","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102357_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207471","article-title":"An integrated polymeric mRNA vaccine without inflammation side effects for cellular immunity mediated cancer therapy","volume":"35","author":"Huang","year":"2023","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102357_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.mtbio.2025.102357_bib43","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat. Nanotechnol."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425009287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425009287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:45:55Z","timestamp":1773164755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425009287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"alternative-id":["S2590006425009287"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102357","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticle-mediated mRNA\/siRNA dual-bioengineered dendritic cell vaccines combined of PD-1\/PD-L1 blockade for boosting tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102357"}}